PMID: 8947929Nov 1, 1996Paper

Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ

Neurochemical Research
D P DevineH Akil

Abstract

We examined the effects of intracerebroventricular (i.c.v.) administration of orphanin FQ (OFQ) on locomotor activity in rats. The rats were habituated to locomotor-testing boxes and then injected i.c.v. with OFQ (0 - 10 nmoles). Acute injections of OFQ produced dose-orderly reductions in horizontal locomotion and rearing activity. This suppression of motor activity was characterized by a disruption of balance and muscle control. Within minutes of i.c.v. injection of the higher doses of OFQ, the rats exhibited flaccid muscle tone. They each lay in an atypical posture, pressing the abdomen against the floor, and splaying the hindlimbs. When these rats locomoted, their gate was unsteady. They wobbled from side to side, and frequently fell over. Repeated daily injections of OFQ resulted in a rapid development of tolerance to the OFQ-induced suppression of locomotion and rearing activity. Tolerance to the observed impairments of motor control were also apparent. In the rats that were repeatedly treated with the highest dose (10 nmol) of OFQ, tolerance to the motoric effects was still apparent after 7 days without OFQ treatment.

References

Oct 28, 1977·Science·D S SegalR Guillemin
Jun 3, 1976·Nature·H H BuscherJ Pless
Jun 19, 1975·Psychopharmacologia·L ShusterB E Eleftheriou
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B L KiefferC G Hirth
Dec 28, 1992·Science·C J EvansR H Edwards
Jan 1, 1991·Pharmacology, Biochemistry, and Behavior·D J Calcagnetti, S G Holtzman
Sep 1, 1985·Pharmacology, Biochemistry, and Behavior·M Amalric, G F Koob
May 1, 1984·Pharmacology, Biochemistry, and Behavior·M UkaiT Kameyama
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·P Vezina, J Stewart
Apr 1, 1995·Laboratory Animals·J S TuliD B Morton
Jan 1, 1995·Journal of Neurochemistry·J E LachowiczD R Sibley
Dec 15, 1994·Biochemical and Biophysical Research Communications·M NishiT Takeuchi
Apr 1, 1994·Pharmacology, Biochemistry, and Behavior·M E MeyerM E Meyer

❮ Previous
Next ❯

Citations

Oct 31, 2002·Psychopharmacology·Kabirullah LutfyNigel T Maidment
Nov 19, 2003·European Journal of Pharmacology·Daniel S MathonGeert M J Ramakers
Aug 19, 2003·European Journal of Pharmacology·Jolanta KotlinskaJerzy Silberring
Apr 4, 1998·European Journal of Pharmacology·J C Meunier
Aug 2, 2002·Pharmacology, Biochemistry, and Behavior·Pawel K OlszewskiAllen S Levine
Jun 17, 1999·Pharmacology, Biochemistry, and Behavior·S Narayanan, N T Maidment
Feb 15, 2002·Behavioural Brain Research·Shridhar NarayananNigel Maidment
Jan 12, 2002·Regulatory Peptides·Gudrun WakoniggAlois Saria
Sep 22, 2000·Peptides·C Mollereau, L Mouledous
Sep 22, 2000·Peptides·J E Grisel, J S Mogil
Sep 22, 2000·Peptides·C PolidoriM Massi
Sep 22, 2000·Peptides·R CiccocioppoM Massi
Jan 1, 1997·Peptides·G A OlsonA J Kastin
Mar 8, 2000·Peptides·L M Harrison, D K Grandy
Aug 26, 1998·Drug and Alcohol Dependence·H AkilS Watson
Apr 18, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matteo MartiMichele Morari
Apr 1, 2000·British Journal of Pharmacology·G Calo'D Regoli
Jul 30, 2002·British Journal of Pharmacology·Fang ZhengSteven W Johnson
Apr 30, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Pawel K OlszewskiAllen S Levine
Jan 24, 2008·Neuroendocrinology·Arnulfo Quesada, Paul Micevych
Jul 18, 2014·Annual Review of Neuroscience·Constance RichterAlexander F Schier
Feb 24, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Elaine C Gavioli, Girolamo Calo'
Jan 29, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Carla PetrellaSimona Agostini
Jul 12, 2005·CNS Drug Reviews·Girolamo CaloDomenico Regoli
Apr 17, 2008·Neurobiology of Disease·Riccardo ViaroMichele Morari
Dec 10, 2003·British Journal of Pharmacology·Alexander KuzminSven Ove Ogren
Apr 17, 2008·British Journal of Pharmacology·B Boutrel
May 26, 2010·CNS Neuroscience & Therapeutics·Girolamo Calo'Remo Guerrini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.